Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2004 1
2005 1
2006 1
2008 2
2009 1
2013 4
2014 4
2015 5
2016 6
2017 2
2018 3
2019 8
2020 6
Text availability
Article attribute
Article type
Publication date

Search Results

42 results
Results by year
Filters applied: . Clear all
Page 1
Mechanisms of Resistance to CDK4/6 Inhibitors: Potential Implications and Biomarkers for Clinical Practice.
McCartney A, Migliaccio I, Bonechi M, Biagioni C, Romagnoli D, De Luca F, Galardi F, Risi E, De Santo I, Benelli M, Malorni L, Di Leo A. McCartney A, et al. Among authors: de luca f. Front Oncol. 2019 Jul 23;9:666. doi: 10.3389/fonc.2019.00666. eCollection 2019. Front Oncol. 2019. PMID: 31396487 Free PMC article. Review.
Cognitive fatigability is a quantifiable distinct phenomenon in multiple sclerosis.
Tommasin S, De Luca F, Ferrante I, Gurreri F, Castelli L, Ruggieri S, Prosperini L, Pantano P, Pozzilli C, De Giglio L. Tommasin S, et al. Among authors: de luca f. J Neuropsychol. 2020 Sep;14(3):370-383. doi: 10.1111/jnp.12197. Epub 2019 Nov 14. J Neuropsychol. 2020. PMID: 31729168
Effect of dalfampridine on information processing speed impairment in multiple sclerosis.
De Giglio L, De Luca F, Gurreri F, Ferrante I, Prosperini L, Borriello G, Quartuccio E, Gasperini C, Pozzilli C. De Giglio L, et al. Among authors: de luca f. Neurology. 2019 Aug 20;93(8):e733-e746. doi: 10.1212/WNL.0000000000007970. Epub 2019 Jul 22. Neurology. 2019. PMID: 31331968 Clinical Trial.
Using CTCs for pharmacogenomic analysis.
Hart CD, Galardi F, Pestrin M, De Luca F, Risi E, Di Leo A. Hart CD, et al. Among authors: de luca f. Pharmacol Res. 2016 Apr;106:92-100. doi: 10.1016/j.phrs.2016.02.019. Epub 2016 Feb 24. Pharmacol Res. 2016. PMID: 26921662 Review.
Prognostic role of serum thymidine kinase 1 activity in patients with hormone receptor-positive metastatic breast cancer: Analysis of the randomised phase III Evaluation of Faslodex versus Exemestane Clinical Trial (EFECT).
McCartney A, Biagioni C, Schiavon G, Bergqvist M, Mattsson K, Migliaccio I, Benelli M, Romagnoli D, Bonechi M, Boccalini G, Pestrin M, Galardi F, De Luca F, Biganzoli L, Piccart M, Gradishar WJ, Chia S, Di Leo A, Malorni L. McCartney A, et al. Among authors: de luca f. Eur J Cancer. 2019 Jun;114:55-66. doi: 10.1016/j.ejca.2019.04.002. Epub 2019 May 3. Eur J Cancer. 2019. PMID: 31059974 Clinical Trial.
Plasma Thymidine Kinase Activity as a Biomarker in Patients with Luminal Metastatic Breast Cancer Treated with Palbociclib within the TREnd Trial.
McCartney A, Bonechi M, De Luca F, Biagioni C, Curigliano G, Moretti E, Minisini AM, Bergqvist M, Benelli M, Migliaccio I, Galardi F, Risi E, De Santo I, Romagnoli D, Biganzoli L, Di Leo A, Malorni L. McCartney A, et al. Among authors: de luca f. Clin Cancer Res. 2020 May 1;26(9):2131-2139. doi: 10.1158/1078-0432.CCR-19-3271. Epub 2020 Jan 14. Clin Cancer Res. 2020. PMID: 31937617
Arterial spin labeling MR imaging for differentiation between high- and low-grade glioma-a meta-analysis.
Falk Delgado A, De Luca F, van Westen D, Falk Delgado A. Falk Delgado A, et al. Among authors: de luca f. Neuro Oncol. 2018 Oct 9;20(11):1450-1461. doi: 10.1093/neuonc/noy095. Neuro Oncol. 2018. PMID: 29868920 Free PMC article.
Molecular and morphological characterisation of Longidoruspolyae sp. n. and L.pisi Edward, Misra & Singh, 1964 (Dorylaimida, Longidoridae) from Bulgaria.
Lazarova SS, Elshishka M, Radoslavov G, Lozanova L, Hristov P, Mladenov A, Zheng J, Fanelli E, Francesca De Luca, Peneva VK. Lazarova SS, et al. Among authors: francesca de luca. Zookeys. 2019 Mar 14;830:75-98. doi: 10.3897/zookeys.830.32188. eCollection 2019. Zookeys. 2019. PMID: 30918443 Free PMC article.
Functional Variation of Two Novel Cellulases, Pv-eng-5 and Pv-eng-8, and the Heat Shock 90 Gene, Pv-hsp-90, in Pratylenchus vulnus and Their Expression in Response to Different Temperature Stress.
Fanelli E, Troccoli A, De Luca F. Fanelli E, et al. Among authors: de luca f. Int J Mol Sci. 2018 Dec 28;20(1):107. doi: 10.3390/ijms20010107. Int J Mol Sci. 2018. PMID: 30597892 Free PMC article.
Plasma thymidine kinase-1 activity predicts outcome in patients with hormone receptor positive and HER2 negative metastatic breast cancer treated with endocrine therapy.
Bonechi M, Galardi F, Biagioni C, De Luca F, Bergqvist M, Neumüller M, Guarducci C, Boccalini G, Gabellini S, Migliaccio I, Di Leo A, Pestrin M, Malorni L. Bonechi M, et al. Among authors: de luca f. Oncotarget. 2018 Mar 27;9(23):16389-16399. doi: 10.18632/oncotarget.24700. eCollection 2018 Mar 27. Oncotarget. 2018. PMID: 29662653 Free PMC article.
42 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback